I am Keshani Hiniduma from the Department of Chemistry, University of Connecticut, USA. I am a bioanalytical chemist who is passionate about developing accessible point of care bioassays. Employing 3D printed microfluidic devices is a major component of my assay development. I am currently working on a CRISPR-based ECL assay for early Alzheimer's disease detection. Additionally, I, together with other bioanalytical chemists, have developed two COVID-19 detection assays where one detects the presence of the virus itself and the other detects the cytokine storm triggered by COVID-19. I have also developed a multiplexed assay to detect multiple cancers.
I am Keshani Hiniduma from the Department of Chemistry, University of Connecticut, USA. I am a bioanalytical chemist who is passionate about developing accessible point of care bioassays. Employing 3D printed microfluidic devices is a major component of my assay development. I am currently working on a CRISPR-based ECL assay for early Alzheimer's disease detection. Additionally, I, together with other bioanalytical chemists, have developed two COVID-19 detection assays where one detects the presence of the virus itself and the other detects the cytokine storm triggered by COVID-19. I have also developed a multiplexed assay to detect multiple cancers.